Group 1 - Chip stocks collectively rose, with notable increases: Beike Micro up 6.94% to HKD 58.7, Zhongdian Huada Technology up 3.8% to HKD 1.64, InnoCare up 2.41% to HKD 102, and Huahong Semiconductor up 2.16% to HKD 52 [1] - On September 13, the Ministry of Commerce announced an anti-dumping investigation into imported analog chips from the United States, effective from September 13, 2025 [1] - The Ministry of Commerce also initiated an anti-discrimination investigation regarding U.S. measures in the integrated circuit sector [1] Group 2 - CITIC Securities noted that major overseas manufacturers like Texas Instruments have been aggressively expanding production and implementing price measures in the domestic market, which has slowed the pace of domestic substitution in the analog chip sector [1] - The recent tariff events since 2025 have increased domestic customers' willingness to substitute, and Texas Instruments' price hikes from June to August indicate a shift in competitive strategy [1] - As the anti-dumping investigation progresses, domestic manufacturers are expected to benefit from a better market environment, leading to potential recovery in profitability [1]

Group 1 - Suzhou has added 5 new companies listed on the Hong Kong Stock Exchange (HKEX) this year, expanding the "Suzhou sector" to 38 companies, with a market capitalization increase from 248.67 billion RMB to 594.50 billion RMB, a growth of 139% [1] - Among the 11 new listed companies in Suzhou this year, nearly half are on the HKEX, including notable firms like Weisheng Pharmaceutical and Zhengli New Energy, which focus on innovative sectors [2] - The market capitalization of Suzhou's A-share listed companies has also seen significant growth, increasing from 1,724.35 billion RMB to 2,476.78 billion RMB, a rise of 43.6% [2] Group 2 - Notable companies in the HKEX sector include Innovent Biologics, which saw its market cap rise from 55.52 billion RMB to 151.65 billion RMB, a 173% increase, driven by a 50.6% year-on-year revenue growth [3] - InnoCare Pharma's market cap increased from 25.44 billion RMB to 82.86 billion RMB, a 226% rise, with significant growth in its AI and data center segments [3] Group 3 - The recent Suzhou (Hong Kong) Financial Cooperation Exchange Conference showcased several companies planning to list in Hong Kong, including Lightyear Intelligent Navigation and Dongwu Pharmaceutical, which are leaders in their respective fields [4][5] - These companies represent key sectors such as autonomous driving, biomedicine, and high-end manufacturing, highlighting Suzhou's transition from "Suzhou manufacturing" to "Suzhou creation" [4] Group 4 - As of the end of August, Suzhou has 11 companies in the process of applying for HKEX listing, with a focus on biomedicine and software services [6] - The HKEX market is seen as beneficial for companies aiming for international development, enhancing brand internationalization and market share [6] Group 5 - Suzhou has established a collaborative mechanism involving financial institutions and local enterprises to support companies through the IPO process, enhancing the integration of local industries with international financial resources [7][8] - Initiatives include training programs and workshops to prepare companies for listing on the HKEX, demonstrating Suzhou's commitment to facilitating access to capital markets [8]

R 英諾賽科（蘇州）科技股份有限公司 InnoScience (Suzhou) Technology Holding Co., Ltd. （於中華人民共和國註冊成立的股份有限公司） 股份代號: 2577 2025 中期報告 攜手共創 美好未來 2025 INTERIM REPORT 中期報告 目錄 英諾賽科（蘇州）科技股份有限公司 2025中期報告 2 釋義 6 公司資料 8 2025年中期財務及業務亮點 10 管理層討論與分析 23 企業管治及其他資料 37 獨立核數師審閱報告 38 綜合損益表 39 綜合損益及其他全面收益表 40 綜合財務狀況表 42 綜合權益變動表 43 綜合現金流量表 44 未經審核中期財務報告附註 釋義 在本中期報告內，除文義另有所指外，下列詞語具有以下涵義： | 「公司章程」或「章程」 | 指 | 本公司公司章程，經不時修訂、補充或以其他方式修改 | | --- | --- | --- | | 「聯繫人」 | 指 | 具上市規則所賦予的涵義 | | 「審核委員會」 | 指 | 本公司董事會審核委員會 | | 「董事會」 | 指 | 本公司董事會 | | 「董事委員會」 | 指 | ...

Market Overview - The Hong Kong stock market indices collectively declined, ending a four-day rally, with market sentiment becoming cautious [1] - The Hang Seng Index fell by 0.43%, barely holding above the 26,000-point mark, while the Hang Seng China Enterprises Index and the Hang Seng Tech Index dropped by 0.73% and 0.24%, respectively [1] Sector Performance - Major technology stocks generally declined, with Meituan dropping 6% to reach a new low, Baidu down 2.38%, JD.com nearly 2%, and Kuaishou down 1% [1] - Biopharmaceutical stocks faced significant losses due to reports of the Trump administration planning to restrict Chinese pharmaceuticals, with innovative drug concept stocks leading the declines. For instance, Gilead Sciences plummeted by 19.66%, while Hansoh Pharmaceutical fell nearly 9% [1] - Other sectors such as film and entertainment, steel, automotive, and domestic real estate stocks also showed weakness [1] Strong Performers - Semiconductor stocks exhibited strong gains, particularly with InnoCare Pharma rising over 9% as it collaborates with NVIDIA to enhance data center operations. SMIC and Hua Hong Semiconductor both increased by approximately 6% [1] - Supported by the prospect of Federal Reserve interest rate cuts, non-ferrous metal stocks, including copper and aluminum, performed actively [1] - Infrastructure-related stocks, including military, Apple concept, building materials, heavy machinery, and high-speed rail construction stocks, also showed active performance [1]

Market Overview - The Hong Kong stock market experienced a collective decline in the morning session, with the Hang Seng Index falling by 0.29% to 26,124.85, the State-Owned Enterprises Index dropping by 0.48% to 9,283.20, and the Hang Seng Tech Index decreasing by 0.09% to 5,897.13. This marks a halt to a four-day upward trend, indicating a shift towards cautious market sentiment after reaching new highs [1]. Sector Performance - Major technology stocks showed weak performance, with Meituan down nearly 4%, Baidu down 2.38%, JD.com down 1.8%, and Xiaomi down over 1%. Tencent remained flat, while Alibaba and NetEase saw slight increases [3]. - The biopharmaceutical sector faced significant declines, particularly in innovative drug companies, with companies like Gilead Sciences dropping nearly 13% and Hansoh Pharmaceutical falling over 9% [3]. - Conversely, semiconductor stocks saw notable gains, led by InnoCare Pharma with an increase of over 10%, and SMIC rising by 6%. Other sectors such as non-ferrous metals, Chinese brokerage firms, heavy machinery, military, education, coal, and Apple-related stocks also experienced upward movements [3]. Notable Stock Movements - The top gainers included InnoCare Pharma (up 10.75%), Nakamura International (up 6.05%), and End Class Non-Semiconductor (up 5.77%). Other notable performers were Chip Intelligence Holdings (up 5.62%) and Shanghai Fuzhi (up 5.60%) [2].

编辑/jayden 消息面上，晶圆代工龙头台积电9月10日公布的营收报告显示，公司2025年8月销售额3357.7亿元新台币，同比增长 33.8%，环比增长3.9%。台积电1—8月累计销售额2.43万亿元新台币，同比增长37.1%。此外，甲骨文日前公布了相 当积极的云业务展望，激发了人们对人工智能基础设施建设正在加速的希望。 港股芯片股早盘集体走高，截至发稿， 大涨超9%， 、 双双涨近6%， 涨近5%。 国投证券指出，今年上半年全球半导体行业保持高景气，中国板块表现突出。增长主要来自两大动力：AI算力需求 持续增长带动代工需求增加，以及设备、材料、零部件等环节国产替代加速。外部环境加速国产替代进程，内部方 面，半导体IPO与并购活跃，资本助力产业升级，龙头企业通过整合稀缺技术增强竞争力。展望下半年，行业将延 续"AI驱动+自主可控"双主线发展。 | 代碼 | 名稱 | 最新價 | 張跌額 | 漲跌幅 ◆ | 成交額 | 總市值 | | --- | --- | --- | --- | --- | --- | --- | | 02577 | 央話賽科 | 101.800 | +8.800 | +9.46% | ...

来源：21世纪经济报道 相关快讯 南方财经9月11日电，港股午间收盘，恒生指数跌0.29%，恒生科技指数跌0.09%。港股半导体板块持续 走强，英诺赛科涨超10%，华虹半导体、中芯国际、上海复旦、宏光半导体等跟涨。港股医药股走弱， 翰森制药跌超9%，石药集团跌超7%，百济神州、复宏汉霖、药明生物等跟跌。 相关股票： 百济神州翰森制药石药集团中芯国际百济神州药明生物中芯国际宏光半导体 南方财经9月11日电，港股午间收盘，恒生指数跌0.29%，恒生科技指数跌0.09%。港股半导体板块持续 走强，英诺赛科涨超10%，华虹半导体、中芯国际、上海复旦、宏光半导体等跟涨。港股医药股走弱， 翰森制药跌超9%，石药集团跌超7%，百济神州、复宏汉霖、药明生物等跟跌。 相关股票： 百济神州翰森制药石药集团中芯国际百济神州药明生物中芯国际宏光半导体 港股午评：恒生指数跌0.29%，恒生科技指数跌0.09% 2025-09-11 12:06 ...

港股上午盘三大指数集体收跌，止步4拉升行情！恒生指数跌0.29%险守26000点关口，国企指数、恒生 科技指数分别下跌0.48%及0.09%。市场做多情绪在连续4日上涨且创阶段新高后开始趋于谨慎。 另一方面，半导体芯片股拉升明显，英诺赛科涨超10%领衔，中芯国际涨6%，铜、铝等有色金属股表 现活跃，中资券商股、重型机械股、军工股、教育股、煤炭股、苹果概念股纷纷上涨。(格隆汇) 盘面上，连续上涨的大型科技股多数表现低迷，其中，美团跌近4%，百度跌2.38%，京东跌1.8%，小米 跌超1%，腾讯飘绿，阿里巴巴、网易小幅上涨；美媒指特朗普考虑对来自中国的药品实施严格限制， 生物医药股大幅下挫，创新药方向跌幅最大，其中，歌礼制药跌近13%，翰森制药跌超9%，石药集 团、百济神州、中国生物制药跟跌；影视娱乐股、新消费概念股、体育用品股、汽车股、航空股普遍走 低。 ...

（文章来源：每日经济新闻） 每经AI快讯，9月11日，港股半导体板块持续走强，英诺赛科涨近8%，华虹半导体、中芯国际涨超 5%，上海复旦涨逾4%。 ...

【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容 的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱： news_center@staff.hexun.com 9月11日消息，港股半导体股集体拉升，英诺赛科涨超7%，华虹半导体涨超4%，先思行、中芯国 际、上海复旦涨超3%。 中信证券研报认为，预计2025年国内先进存储晶圆厂扩产需求保持稳定；2026年随着新产线的落地 有望快速提升，叠加上游环节的国产替代需求，有望带动国内半导体设备、零部件和材料环节的需求加 速成长。 (责任编辑：宋政 HN002) ...